See why investors love the new 12-month forecast for BioCryst Pharmaceuticals Inc(BCRX)

man woman technology room

Market Data

BioCryst Pharmaceuticals Inc(BCRX) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about BCRX. We will be studying the movement so you can make the best decision as an investor. The stock has moved downwards today by 0.41%. The high for today is 12.37 and today’s low is 11.95. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending downwards, which means the volume of people selling this stock is greater than people buying it.

Company Description

BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines. It focuses on the oral treatments for rare diseases in which significant unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. The company was founded in 1986 and is headquartered in Durham, NC.

Stock Forecast

As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for BioCryst Pharmaceuticals Inc is $19.00 and the low forecast is $15.00. Overall, BioCryst Pharmaceuticals Inc is in great shape going forward. They have a strong market cap of $2.13B and a very bright future ahead of them.

Leave a Reply

%d bloggers like this: